Ask an Expert

Schahram Akbarian, M.D., Ph.D. Scientific Council Member 1993, 2000 NARSAD Young Investigator Grantee 1997 Klerman Prizewinner Professor of Psychiatry and Neuroscience Chief of the Division of Psychiatric Epigenomics Mount Sinai School of Medicine, expert on mental illness
Q Is there a time frame for being able to reverse or to stop the insults that occur to DNA?
A We do not know. To ‘rewrite’ the epigenetic code, or repair insults that occurred to... More >
Rachel G. Klein, Ph.D., Scientific Council Member, 1995 NARSAD Distinguished Investigator Grantee, 2004 Ruane Prize for Outstanding Achievement in Child & Adolescent Psychiatric Research, Professsor of Psychiatry, New York University Child Study Center, Expert on Childhood mental illnesses including ADHD and anxiety
Q In your time on the Scientific Council, what is the most promising area of brain and behavior research you’ve seen?
A Two areas appear most promising. One is that great progress has been made in... More >
Jeffrey A. Lieberman, M.D., Columbia University Medical Center
Q Where will the breakthroughs come in treating schizophrenia?
A “The single biggest thing that would aid research in mental illnesses and the... More >
Bryan Roth, M.D., Ph.D.
Q Is there a link between vitamin D3 deficiency and schizophrenia?
A There are several studies which have suggested some link between both high and low... More >
Bryan Roth, M.D., Ph.D.
Q How long will it take to get real improvements in treatment for illnesses like schizophrenia?
A There are several novel medications in both early- and later-stage clinical... More >
Jeffrey A. Lieberman, M.D., Columbia University Medical Center
Q What is the benefit of early intervention in treating schizophrenia - and how is it possible?
A “The ability to treat people who develop schizophrenia successfully, produce... More >
Jeffrey A. Lieberman, M.D., Columbia University Medical Center
Q What is ‘recovery’ for a patient with Schizophrenia?
A “They have an illness, they may continue to have some level of symptoms, but it’s... More >
Bryan L. Roth, M.D., Ph.D.
Q How does a personal connection to mental illness impact the work you do?
A I’m reminded on a daily basis how far we’ve come and yet how far we need to go to... More >
Schahram Akbarian, M.D., Ph.D. Scientific Council Member 1993, 2000 NARSAD Young Investigator Grantee 1997 Klerman Prizewinner Professor of Psychiatry and Neuroscience Chief of the Division of Psychiatric Epigenomics Mount Sinai School of Medicine, expert on schizophrenia
Q There are endless genetic studies for mental illness and yet the treatments don’t seem to be getting better. Why is there still such an emphasis on understanding the genetics?
A This is an excellent question. Once a disease-associated gene has been found,... More >
Schahram Akbarian, M.D., Ph.D. Scientific Council Member 1993, 2000 NARSAD Young Investigator Grantee 1997 Klerman Prizewinner Professor of Psychiatry and Neuroscience Chief of the Division of Psychiatric Epigenomics Mount Sinai School of Medicine, Expert on mental illness
Q If epigenetics is related to environmental influences triggering a susceptibility to mental illness—do you know particular ones leading to schizophrenia?
A A number of environmental influences acting on the developing brain are suspected to... More >

Pages